Attenuation of some metabolic deteriorations induced by diabetes mellitus using carnosine

Journal of Applied Sciences

Volumn 7, Issue 16, 2007, Pages 2252-2260

  Soliman, K M ^a   Mohamed, A M ^b   Metwally, N S ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Carnosine; Cortisol; Diabetes; Glucose; Iron; Lipid profiles; Liver functions; Serum

Indexed keywords

AMINO ACIDS; ANIMALS; CHOLESTEROL; CORTISOL; DETERIORATION; GLUCOSE; IRON; MEDICAL PROBLEMS; METABOLISM; PHYSIOLOGY;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE METABOLISM; CARNOSINE; LIPID PROFILE; LIVER FUNCTIONS; SERUM; SORBITOL DEHYDROGENASE;

BODY FLUIDS;

EID: 34848845284     PISSN: 18125654     EISSN: 18125662     Source Type: Journal    
DOI: 10.3923/jas.2007.2252.2260     Document Type: Article

References (78)

1. Abdel-Mageed, N.A., 2005. Efficacy of some antioxidants on center biochemical parameters in blood of diabetic rats. Egypt. Pharm. J., 4: 125-134.
2. Abou-Seif, M.A.M. and H. Youssef, 2001. Oxidative stress and male IGF1 gonadotropin and related hormones in diabetic patients. Clin. Chem. Lab. Med., 39: 618-623.
3. Abou-Seif, M.A.M. and A. Youssef, 2004. Evaluation of some biochemical changes in diabetic patients. Clin. Chim. Acta, 346: 161-170.
4. Amaral, M.E., H.C. Oliveira, E.M. Carneiro, V.D. Augusto, E.C. Vieira, J.A. Berti and A.C. Boschero, 2002. Plasma glucose regulation and insulin secretion in hypertriglyceridemic mice. Horm. Metab. Res., 34: 21-26.
5. Anwar, M.M. and A.M.A. Meki, 2003. Oxidative stress in Streptozotocin-induced diabetic rats: Effects of garlic oil and melationin. Compar. Biochem. Physio.-part A, 135: 539-547.
6. Arakawa, H., M. Maeda and A. Tsuji, 1979. Chemiluminescence enzyme immunoassay of cortisol using peroxidase as label. Anal. Biochem., 97: 248-254.
7. Babizhayer, M.A., M.C. Seguin, J. Gueyne, R.P. Evstigneeva, E.A. Ageyeva and G.A. Zheltukhin, 1994. L. carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanyl-histamine) act as natural antioxidants with hydroxyl-radical scavenging and lipid peroxidase activities. Biochem. J., 304: 509-516
8. Baran, E.J., 2000. Metal complexes of carnosine. Biochemistry, 65: 789-797.
9. Berger, S., 1985. Incidence of severe side effects during therapy with sulphonylurea and biguanides. Hormone Metabolic Res., 17: 111-115.
10. Bergmeyer, H.U., 1974. Sorbitol Dehydrogenase. In: Methods of Enzymatic Analysis. 3rd Edn., Verlay Chemie, Weinheim, Academic Press, London, pp: 569-573.
11. Bergmeyer, H.U. and E. Bernt, 1974. Determination of Transaminases. In: Methods of Enzymatic Analysis. 2nd Edn., Vol. 2, Verlag Chemie, Weinheim, Academic Press, London, pp: 279.
12. Bhagavan, N.V., 2001. Biological Actions of Cortisol. In: Medical Biochemistry. 4th Edn., Donaghy, N. and J. Hayunurst (Eds.), Academic Press, London, pp: 755.
13. Bitar, M.S., 1998. Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. Am. J. Pathol., 152: 547-553.
14. Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813-820.
15. Cameron, O.G., B. Thomas, D. Tiongeo and J. Gredez, 1987. Hypercortisolism in diabetes mellitus. Diab. Care, 10: 662-664.
16. De Carvalho, E.N., L.M. Ferreira, N.A.S. De Carvalho, L.E.F. Abla and R.E. Liebano, 2005. Viability of a random pattern dorsal skin flap, in diabetic rats. Acta Cir. Bras., 20: 3.
17. Duckworth, W.C., 2001. Hyperglycemia and cardiovascular disease. Curr. Atheroscler, Rep., 3: 383-391.
18. Emerick, A.J., M.P. Richards, G.L. Kartje, E.J. Neafsey and E.B. Jr. Stubbs, 2005. Experimental diabetes attenuates cerebral cortical-evoked forelimb motor responses. Diabetes, 54: 2764-2771.
19. Friedewald, W.T., R.I. Ievy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18: 499-502.
20. Giugliano, D., A. Cericllo and G. Paolisso, 1995. Diabetes mellitus hypertension. Cardiovascular disease: Which role for oxidative stress? Metabolism, 44: 363-368.
21. Goldberg, R.B., 2003. Cardiovascular disease in patients who have diabetes. Cardiol. Clin., 21: 399-413.
22. Goldstein, R.E., A.D. Cherrington, G.W. Reed, D.B. Lacy, D.H. Wasserman and N.N. Abumrad, 1994. Effects of chronic hypercortisolemia on carbohydrate metabolism during insulin deficiency. Am. J. Physiol., 266: E618-E627.
23. Gull M., D.E. Laaksonen, M. Atalay, L. Vider and O. Hanninen, 2002. Effects of endurance training on tissue glutathione homeostasis and lipid peroxidation in streptozotocin-induced diabetic rats. Scand. J. Med. Sci. Sports, 12: 163-170.
24. Halliwell, B., 1993. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23 Suppl., 1: 118-126.
25. Hardman, J.G. and L.E. Limbird, 2001. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Edn., New York: McGraw-Hill, pp: 1399.
26. Hipkiss, A.R., 1998. Carnosine, a protective anti-ageing peptide. Int. J. Biochem. Cell Biol., 30: 863-868.
27. Hristova, M. and L. Aloe, 2006. Metabolic syndrome-Neurotrophic hypothesis. Medical Hypotheses, 66: 545-549.
28. Hwang, I.K., V.L. Go, D.M. Harris, I. Yip, K.W. Kang and M.K. Song, 2003. Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice. Diabetes Obes. Metab., 5: 317-324.
29. Ikeda, Y., T. Suehiro, S. Yamanaka, Y. Kumon, H. Takata, S. Inada, N. Ogomi, F. Osaki, M. Inoue, K. Arii and K. Hashimoto, 2006. Association between serum ferritin and circulating oxidized low-density lipoprotein levels in patients with type 2 diabetes. Endocr. J. Doi: 10-1507, k 06-010.
30. Juckett, M.B., J. Balla, G. Balla, J. Jessurun, H.S. Jacob and G.M. Vercellotti, 1995. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am. J. Pathol., 147: 782-789.
31. Kalousova, M., J. Skrha and T. Zina, 2002. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res., 51: 597-604.
32. Kang, J.H., K.S. Kim, S.Y. Choi, H.Y. Kwon,M.H. Wonn and T.C. Kang, 2001. Protection by carnosine-related dipeptides against hydrogen peroxide-mediated ceruloplasmin modification. Mol. Cells, 13: 107-112.
33. Krentz, A.J., 2003. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes. Metab., 5: S19-S27.
34. Krha, J., M. Prazny, J.I. Hilgertova and H. Weiserova, 2003. Serum alpha tocopherol and ascorbic acid concentrations in type 1 and type 2 diabetic patients with and without angiopathy. Clin. Chim. Acta, 329: 103-108.
35. Latner, A., 1958. In: Clinical Biochemistry. Saunders, Philadelphia, pp: 48.
36. Lee, D.H., D.Y. Liu, D.R.J. Jr, H.R. Shin, K. Song, I.K. Lee, B. Kim and R.C. Hider, 2006. Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care, 29: 1090-1095.
37. Lee, J.W., H. Miyawaki, E.V. Bobst, J.D. Hester, M. Ashraf and A.M. Bobst, 1999. Improved functional recovery of ischemic rat hearts due to singlet oxygen scavengers histidine and carnosine. J. Mol. Cell Cardiol., 31: 113-121.
38. Lee, Y.T., C.C. Hsu, M.H. Lin, K.S. Liu and M.C. Yin, 2005. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur. J. Pharmacol., 513: 145-150.
39. Levinthal, G.N. and A.S. Tavill, 1999. Liver disease and diabetes mellitus. Clin. Diabetes, 17: 73.
40. Lundberg, U., 2005. Stress hormones in health and illness: The Role of Work and Gender Psychoneuroendocrinology, 30: 1017-1021.
41. Merzouk, H., S. Madani, D. Chabane, J. Prost, M. Bouchenak and J. Belleville, 2000. Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring rats with sreptozotocin-induced diabetes. Clin. Sci., 98: 21-30.
42. Milani, E., S. Nikfar, R. Khorasani, M.J. Zamani and M. Abdollahi, 2005. Reduction of diabetes-induced oxidative stress by phosphodiestrase inhibitors in rats. Comparative Biochemistry and Physiology Part C: Toxicology Pharmacol., 140: 251-255.
43. Morel, D.W. and G.M. Chisolm, 1989. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J. Lipid Res., 30: 1827-1834.
44. Nagai, K., T. Suda, K. Kawasaki and Y. Yamaguchi, 1990. Acceleration of metabolism of stress-related substances by L-carnosine. Nippon Seirigaku Zasshi, 52: 221-228.
45. Nagai, K., A. Niijima, T. Yamano, H. Otani, N. Okumra, N. Tsuruoka, M. Nakai and Y. Kiso, 2003. Possible role of L-carnosine in the regulation of blood glucose through controlling autonomic nerves. Exp. Biol. Med., 228: 1138-1145.
46. Piedrola, G., E. Novo, F. Escober and R. Garcia-Robles, 2001. White blood cell count and insulin resistance in patients with coronary artery disease. Ann. Endocrinol., 62: 7-10.
47. Pleho, A., B. Heljic and N. Viso, 1994. Pathogenic uncertain ties in diabetes mellitus affected by condition of aggression (war), Medicinski Arh., 48: 51-53.
48. Price, D.L., P.M. Rhett, S.R. Thorpe and J.W. Baynes, 2001. Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem., 276: 48967-48972.
49. Radahmadi, M., F. Shadan, S.M. Karimian, S.S. Sadr and A. Nasimi, 2006. Effects of stress on exacerbation of diabetes mellitus, serum glucose and cortisol level and body weight in rats. Pathophysiology, 13: 51-55.
50. Ravikumar, P. and C.V. Anuradha, 1999. Effect of Fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats. Phytother. Res., 13: 197-201.
51. Robertson, R.P., 2004. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem., 279: 42351-42354.
52. Roe, J.H., 1961. Measurement of Vitamin E. In: Standard Methods of Clinical Chemistry. Seligson, D. (Ed.), Vol. III. New York: Academic Press.
53. Rosen, P., P.P. Nawroth, G. King, W. Moller, H.J. Tritschler and L. Packer, 2001. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a congress series sponsored by UNESCOI-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev., 17: 189-212.
54. Roy, M., B. Collier and A. Roy, 1990. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic out patients, Psychol. Res., 31: 31-37.
55. Roy, M.S., A. Roy, W.T. Gallucci, B. Gollier, K. Young, T. Kamilaris and G.P. Chrousos, 1993. The ovine corticotropin-releasing hormone stimulation test in type 1 diabetic patients and controls: Suggestion of mild chronic hypercortisolism. Metabolism, 42: 696-700.
56. Saxena, R., V. Madhu, R. Shukla, K.M. Prabhu and J.K. Gambhir, 2005. Postprandial hypertriglyceridemia and oxidative stress in patients of type 2 diabetes mellitus with macrovascular complications. Clin. Chim. Acta, 359: 101-108.
57. Sherlock, S., 1951. In Liver Diseases Churchill, London, pp: 204.
58. Shirwaikar, A., K. Rajendran, C.D. Kumar and R. Bodla, 2004. Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin-nicotinamide type 2-diabetic rats. J. Ethnopharmacol., 91: 171-175.
59. Silaeva, S.A., V.A. Golenchenko and A.V. Gavril'chak, 1992. Effects of carnosine and 4-methyluracil on the course of experimental hepatitis in rats. Biokhimiya, 57: 1366-1372.
60. Soliman, K.M., M. Abdel-Aziz, Y.H. Nassar, S. Abdel-Sattar and A. El-Ansary, 2002. Effects of carnosine on bilharzial infestation in hamsters: Biochemical and histochemical studies. Comp. Biochem. Physiol., 131: 535-542.
61. Soliman, K.M., A.M. Mohamed and N.S. Metwally, 2004. Hepato and renocorrective effects of cornosine and fluvastatin against hypercholesterolemic stress. Egypt. Pharm. J., 3: 123-145.
62. Stein, E.A., 1986. In: Textbook of Clinical Chemistry. Saunders, W.B. and N.W. Tietz (Eds.), Philadelphia, pp: 879-886, 1818-1829.
63. Steinberg, D., 1997. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem., 272: 20963-20966.
64. Strippoli, G.F., S. Dipaolo, R. Cincione, A.M. Dipalma, A. Teutonico, G. Grandaliano, F.P. Schena and L. Gesualdo, 2003. Clinical and therapeutic aspects of diabetic nephropathy. J. Nephrol., 16: 487-499.
65. Sulieman, M., R. Asleh, Z.I. Cabantchik, W. Breuer, D. Aronson, A. Suleiman, R. Miller-Lotan, H. Hammrman and A.P. Levy, 2004. Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes. Diabetes Care, 27: 2730-2732.
66. Sumana, G. and S.A. Suryawashi, 2001. Effect of Vinca rosa extracts in treatment of alloxan diabetes in male albino rats. Ind. J. Exp. Biol., 39: 748-758.
67. Thornalley, P.J., 2002. Glycation in diabetic neuropathy: Characteristics, consequences, causes and therapeutic options. Int. Rev. Neurobiol., 50: 37-57.
68. Tromblay, P.Q., M.S. Horning and L.J. Blakemore, 2000. Interactions between carnosine and zinc and copper: Implications for neuromodulation and neuroprotection. Biochemistry (Mosc.), 65: 807-816.
69. Tsutsumi, K., Y. Inoue and C. Yoshida, 1999. Acceleration of development of diabetic cataract by hyperlipidemia and low high-density lipoprotein in rats. Biol. Pharm. Bull., 22: 37-41.
70. Ukeda, H., Y. Hasegawa, Y. Harada and M. Sawamura, 2002. Effect of carnosine and related compounds on the inactivation of human Cu, Zn superoxide dismutase by modification of fructose and glycolaldehyde. Biosci. Biotechnol. Biochem., 66: 36-43.
71. Vincent, A.M., M. Brownlee and J.W. Russell, 2002. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N.Y. Acad. Sci., 959: 368-383.
72. Wahlefeld, A.W., 1974. In: Method of Enzymatic Analysis, Vol. 5. Bergmeyer, H.U. (Ed.), Academic Press, New York, pp: 1831-1835.
73. Weissman, N.P. and V.J. Leggi, 1974. In: Clinical Chemistry. Principles and Tehcnics. 2nd Edn., Henry, R.J., D.C. Cannon and J.W. Winkelman (Eds.), Harper and Row, pp: 692-693.
74. Witzlum, U., 1994. The oxidation hypothesis of atherosclerosis. Lancet, 344: 793-795.
75. Yamano, T., A. Niijima, S. Limori, N. Tsuruoka, Y. Kiso and K. Nagai, 2001. Effect of L-carnosine on the hyperglycemia caused by intracranial injection of 2-deoxy-D-glucose in rats. Neurosci. Lett., 313: 78-82.
76. Yan, S.D., A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky and D. Stern, 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/ binding proteins. J. Biol. Chem., 269: 9889-9897.
77. Yan, H. and J.J. Harding, 2005. Carnosine protects against the inactivation of esterase induced by glycation and a steroid. Biochem. Biophys. Acta, 1741: 120-126.
78. Yaryura-Tobias, J.A., A. Pinto and F. Neziroglu, 2001. Anorexia nervosa, diabetes mellitus, brain atrophy and fatty liver. Int. J. Etiol. Disorders, 30: 350-353.